[Cephalothin in internal medicine, with special reference to the treatment of grave hospital infections].
D000038:Abscess / Q000188:drug therapy; D000328:Adult; D000368:Aged; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D001996:Bronchopneumonia / Q000188:drug therapy; D002481:Cellulitis / Q000188:drug therapy; D002512:Cephalothin / Q000494:pharmacology / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy*; D004698:Endocarditis, Subacute Bacterial / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010612:Pharyngitis / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy; D014069:Tonsillitis / Q000188:drug therapy
D002512:Cephalothin
La cefalotina in medicina interna, con particolare riguardo al trattamento delle infezioni ospedaliere gravi.